Precision genomics is moving from the lab into the operational core of health systems — yet translating that clinical capability into enterprise value remains a challenge for many. Health systems are under increasing pressure to reduce operational burden, standardize care,…
Presented by:
James Stover, PhD
General Manager, Health Systems, Natera., Inc
Cardiovascular risk assessment is evolving, with the 2026 ACC/AHA Dyslipidemia Guideline now recommending that every adult have lipoprotein(a) — Lp(a), an inherited cardiovascular risk factor — measured at least once in a lifetime. The 2026 American College of Cardiology/American Heart…
On Demand
Presented by:
Donald M. Lloyd-Jones, MD, ScM, FAHA, FACC
Alexander Graham Bell Professor, Director of the Framingham Center for Population and Prevention Science, PI of the Framingham Heart Study, and Section Chief of Preventive Medicine and Epidemiology in the Department of Medicine Boston University School of Medicine
Frank Qian, MD, MPH
Clinical Instructor Boston University School of Medicine
Many hospitals still rely on generic clinical risk scores to flag high-risk patients. The challenge: those scores aren’t built to map to how CMS Star Ratings, HRRP, VBP and Leapfrog measure performance — which means quality improvement effort can be…
Presented by:
Nik Rao
CEO, Dexur
Caring for patients with recurrent pericarditis often requires navigating uncertainty, repeated flares and fragmented care pathways. This webinar offers a closer look at how programs are addressing these challenges through structured, evidence-informed care models. Clinicians from Oregon Health & Science…
On Demand
Presented by:
David M. German, MD, MPH, FACC
Assistant Professor of Medicine, Knight Cardiovascular Institute, Oregon Health & Science University
Dor Lotan, MD
Medical Director, Center for Pericardial Diseases and NYP Centralized Heart Failure Management Program, Columbia University Irving Medical Center-New York Presbyterian Hospital
Jordan Lindekens, AGACNP, MSN
Nurse Practitioner, Center for Advanced Cardiac Care, New York Presbyterian/Columbia University Irving Medical Center
An underrecognized, genetically inherited risk factor may be quietly accelerating cardiovascular disease in patients you’re already treating — and routine workups won’t catch it. Lipoprotein(a), or Lp(a), has an emerging and increasingly documented role in aortic stenosis and peripheral arterial…
On Demand
Presented by:
Dr. Marc P. Bonaca MD, MPH, FACC, FAHA
Executive Director of Colorado Prevention Center, Aurora, CO, USA Director of Vascular Research, Tenured Professor of Medicine, University of Colorado Anschutz, Aurora, CO, USA Chair of the AHA PAD Collaborative Past Chair of the ACC Vascular Disease Section Leadership Council
Nishant Shah, MD
Assistant Professor, Medicine and Cardiovascular Disease Prevention Lead for the Duke Health System Remote Lipid Monitoring Program Clinical lead in the implementation of Inclisiran across Duke Health System DCRI for a study that evaluates the effectiveness of PCSK9 inhibitors in the Prevention of Cardiovascular Disease
Lp(a) is one of the most clinically meaningful — and most under-tested — cardiovascular risk factors in routine practice. Inaccurate assays, inconsistent reporting standards and disparities in testing across patient populations leave many at-risk patients undiagnosed and undertreated. This on-demand…
On Demand
Presented by:
Howard S. Weintraub, MD, FACC, FAHA, FASPC
Clinical Professor of Medicine, NYU Grossman School of Medicine Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
Leslie J. Donato, Ph.D., D(ABCC)
Co-Director Clinical Specialty Laboratory Co-Director Hospital Clinical Laboratory and Point of Care Associate Professor, Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology at Mayo Clinic
The One Big Beautiful Bill Act has enacted more than $1 trillion in Medicaid reductions over the next decade. As reimbursement tightens and patients arrive later with more advanced conditions, the cost of preventable, non-reimbursable infections is climbing. Waterborne pathogens…
Presented by:
David Pierre
Director of Water Safety Programs LiquiTech ASSE 12080 Certified Legionella Water Safety and Management Specialist
Jack Murphy
Vice President, Technology Solutions LiquiTech ASSE 12080 Certified Legionella Water Safety and Management Specialist
Clinical Documentation Integrity (CDI) teams play a critical role in ensuring diagnoses are accurate, supported, and reflective of the care delivered. But as charts grow more complex and payer scrutiny of retrospective documentation review increases, changes to documentation that happen…
Presented by:
Dr. David Kirk, MD
Chief Medical Officer, Regard
Fran Jurcak MSN, RN, CCDS, CCDS-O
Independent Consultant - CDI and Revenue Cycle
Nio Queiro, CEO
The Queiro Group
Dr. Carolyn Bauer
Medical Director of Clinical Documentation, Montefiore
Health systems are under pressure to manage rising demand, constrained capacity and increasingly complex patient flow. In this discussion, physician leaders from Jefferson Health, Ochsner Health, and Tampa General Hospital will share how they are redesigning care delivery and building…
Presented by:
Dr. Angela M. Nicholas, MD, FAAFP
Chief Clinical Officer, North Region, Jefferson Health
Dr. Logan Davies, MD, MBA
Hospital Medical Director of Access and Throughput, Ochsner Health
Dr. Asa Oxner, MD
VP, Associate CMO of Ambulatory Services, Tampa General Hospital
Dr. Clay Watson, MD
Chief Medical Officer, myLaurel
Learn how aligning IT and care management reduced avoidable length of stay, improved throughput, and strengthened system-wide performance This webinar is on-demand and can be viewed at your convenience. Length of stay is one of the most significant sources of…
On Demand
Presented by:
Jeannine Nylaan MSN, RN
Corporate Executive Director, Care Management, AdventHealth
Rob Dixon RN, MHSA
Executive Director, Clinical & Revenue Systems, Information Technology, AdventHealth
Russ Graney
Chief Executive Officer, Aidin
